• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫西沙星诱导的QTc效应的统计学特征。

Statistical characteristics of moxifloxacin-induced QTc effect.

作者信息

Yan Lihan K, Zhang Joanne, Ng Moh Jee, Dang Qianyu

机构信息

Division of Biometrics VI, Office of Biostatistics/Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

出版信息

J Biopharm Stat. 2010 May;20(3):497-507. doi: 10.1080/10543400903581945.

DOI:10.1080/10543400903581945
PMID:20358432
Abstract

Moxifloxacin has been the most commonly used positive control in "thorough" QTc (TQT) studies. In a TQT study, the assay sensitivity is often considered to be established if the baseline corrected mean difference in QTc between moxifloxacin and placebo is greater than 5 ms in common practice at one or more prespecified time points and the observed moxifloxacin induced QTc effect over time follows the proper pharmacokinetics profile. To better understand the statistical characteristics of moxifloxacin-induced QTc prolongation and to provide guidance for future studies, 20 TQT studies that involved moxifloxacin have been evaluated. We study the QTc profile of the baseline adjusted mean difference in QTc between moxifloxacin and placebo over time. Zhang (2008) proposed that the moxifloxacin induced QTc effect can be evaluated between 1 and 4 h after a single dose (400 mg) administration near the time (T(max)) of peak concentration instead of all time points (typically 9-12 time points) at which QT was measured for the study drug evaluation. After evaluating 20 TQT studies, we confirm that the maximum moxifloxacin effect occurs in the time window between 1 and 4 h post dose. We also investigate the variability of the data as well as correlations between time points and between regimens. These findings and results can be used as a reference for future studies.

摘要

莫西沙星一直是“全面”的QTc(TQT)研究中最常用的阳性对照药。在一项TQT研究中,如果在一个或多个预先指定的时间点,莫西沙星与安慰剂之间的基线校正QTc平均差异在常规情况下大于5毫秒,并且观察到的莫西沙星诱导的QTc效应随时间的变化遵循适当的药代动力学特征,那么通常认为该检测方法具有敏感性。为了更好地了解莫西沙星诱导的QTc延长的统计特征,并为未来的研究提供指导,我们评估了20项涉及莫西沙星的TQT研究。我们研究了莫西沙星与安慰剂之间的基线校正QTc平均差异随时间的QTc变化情况。Zhang(2008年)提出,莫西沙星诱导的QTc效应可以在单次给药(400毫克)后1至4小时内,在接近峰浓度时间(T(max))时进行评估,而不是在研究药物评估中测量QT的所有时间点(通常为9至12个时间点)进行评估。在评估了20项TQT研究后,我们确认莫西沙星的最大效应出现在给药后1至4小时的时间窗口内。我们还研究了数据的变异性以及时间点之间和给药方案之间的相关性。这些发现和结果可作为未来研究的参考。

相似文献

1
Statistical characteristics of moxifloxacin-induced QTc effect.莫西沙星诱导的QTc效应的统计学特征。
J Biopharm Stat. 2010 May;20(3):497-507. doi: 10.1080/10543400903581945.
2
Statistical consideration in testing for assay sensitivity in a "thorough" QT study.“全面”QT研究中检测分析灵敏度时的统计学考量。
J Biopharm Stat. 2010 May;20(3):641-53. doi: 10.1080/10543400903582042.
3
Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.舒更葡糖钠与QT/QTc间期延长无关:一项静脉注射莫西沙星对照的全面QT研究的方法学方面
Int J Clin Pharmacol Ther. 2012 Aug;50(8):595-604. doi: 10.5414/CP201693.
4
Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.左乙拉西坦对健康受试者心脏复极化的影响:一项单剂量、随机、安慰剂和阳性对照、四交叉研究。
Clin Ther. 2008 Feb;30(2):260-70. doi: 10.1016/j.clinthera.2008.02.002.
5
Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies.莫西沙星的群体药代动力学和浓度- QTc 模型:20 项全面 QTc 研究的汇总分析。
J Clin Pharmacol. 2011 Aug;51(8):1152-62. doi: 10.1177/0091270010381498. Epub 2011 Jan 12.
6
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.阿瑞匹坦或其前体药物福沙匹坦对健康受试者QTc间期无影响。
Anesth Analg. 2009 Aug;109(2):418-25. doi: 10.1213/ane.0b013e3181ac1066.
7
Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.一种概率方法在遥测食蟹猴中测定药物诱导的QT间期延长的应用:莫西沙星的作用
J Pharmacol Toxicol Methods. 2007 May-Jun;55(3):227-37. doi: 10.1016/j.vascn.2006.09.002. Epub 2006 Sep 15.
8
A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.在全面QT研究中,对安慰剂和莫西沙星给药后的QT数据进行的统计评估。
J Biopharm Stat. 2008;18(3):502-16. doi: 10.1080/10543400801995460.
9
Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.使用多次给药前基线心电图对莫西沙星的QTc进行周期校正,是所测试的4种方法中变异性最小的。
J Clin Pharmacol. 2009 May;49(5):534-9. doi: 10.1177/0091270008330158. Epub 2009 Mar 13.
10
A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.一项单次、交叉、安慰剂和莫西沙星对照研究,旨在评估奈拉替尼(HKI-272)对健康成年受试者心脏复极的影响。
Clin Cancer Res. 2010 Aug 1;16(15):4016-23. doi: 10.1158/1078-0432.CCR-10-0280. Epub 2010 Jul 20.

引用本文的文献

1
Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers. Tucatinib 对健康志愿者心脏复极的影响。
Drugs R D. 2023 Dec;23(4):411-419. doi: 10.1007/s40268-023-00440-8. Epub 2023 Sep 26.
2
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.利福平耐药结核病治疗中多药方案中使用一种或多种延长 QT 间期药物导致 QT 间期延长:两项儿科研究结果。
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0144822. doi: 10.1128/aac.01448-22. Epub 2023 Jun 26.
3
Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.
在健康受试者中,德瓦鲁单抗对心电图无影响。
Clin Pharmacol Drug Dev. 2022 Apr;11(4):442-453. doi: 10.1002/cpdd.1056. Epub 2022 Feb 19.
4
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosis.利奈唑胺治疗耐多药肺结核患者的 QTc 间期和转氨酶水平的暴露-安全性分析。
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1538-1549. doi: 10.1002/psp4.12722. Epub 2021 Oct 22.
5
The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects.鞘氨醇葡萄糖苷合成酶抑制剂卢昔雷斯特对心脏复极的影响:在健康受试者中进行的全面 QT 研究结果。
Orphanet J Rare Dis. 2020 Oct 27;15(1):303. doi: 10.1186/s13023-020-01582-7.
6
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects.司美格鲁肽无QTc间期延长:一项在健康受试者中的全面QT研究
Diabetes Ther. 2018 Aug;9(4):1441-1456. doi: 10.1007/s13300-018-0442-0. Epub 2018 May 24.
7
Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.莫西沙星在中国健康志愿者中的群体药代动力学及其浓度-QT间期关系建模
Acta Pharmacol Sin. 2017 Nov;38(11):1580-1588. doi: 10.1038/aps.2017.76. Epub 2017 Jul 17.
8
Moxifloxacin Increases Heart Rate in Humans.莫西沙星可提高人体心率。
Antibiotics (Basel). 2017 Feb 5;6(1):5. doi: 10.3390/antibiotics6010005.
9
Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects.卡替拉韦对健康受试者心脏复极的影响。
Clin Pharmacol Drug Dev. 2016 Nov;5(6):509-516. doi: 10.1002/cpdd.272. Epub 2016 Jun 22.
10
Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.在QT研究中确定检测灵敏度:莫西沙星在早期临床药理学研究中的应用经验及其与在全面QT研究中的效果比较。
Eur J Clin Pharmacol. 2015 Dec;71(12):1451-9. doi: 10.1007/s00228-015-1959-z. Epub 2015 Oct 1.